Sudhichai Chokekijchai, M.D., FRCP (Thai). 15th, 1960 Nationality: Thai Gender: Marital Status: Single Education: 1990: Fellow of Thai Royal College of Physician, Bangkok Hospital, Mahidol University, Bangkok 1984: B.Sc , Mahidol University, Bangkok Language: Thai, English Address: 17/258 Prachachuen Rd., Tungsonghong, Laksri, Bangkok 1210, Thailand Current Professional Affiliation:
Member of Thai Royal college of Physician Member of Thai Allergy and Immunology Association Member of Thai Infectious Diseases Association
Career history: 1987-1998 Government Official Director Chief Resident, Internal Medicine Staff of Allergy and Immunology Unit
• National Cancer Institute ( 1995-1996), USA
General fellowship (Research in HIV drug) Staff of Allergy and Immunology Unit Sep 1997 to Sep 1998 Bristol-Myers (Thailand) Bangkok, Thailand • Medical Director Sep 1998 to Dec 2000 Eli-Lilly Asia Inc. Thailand Branch Bangkok, Thailand • Medical Director Jan 2001 to Aug 2008 AstraZeneca (Thailand) Ltd. • Medical director Sep 2008 to present Novartis (Thailand) Ltd. • Chief Scientific Officer
1) Xu ZQ, Qiu Y-L Chokekijchai S, Mitsuya H, Zemlicka J. Unsaturated Acyclic Analogues of 2’- Deoxyadenosine and Thymidine Containing Fluoride: synthesis and Biological Activity. Journal of Med. Chem. 1995, 38: 875-882
2) Shirasaka T, Kavlick MK, Ueno T, Gao W-Y, Kojima E, Alcide ML, Chokekijchai S, Roy BM,
Arnold E, Yarchoan R, Mitsuya H. Emergence of Human immunodeficiency Virus Type I Variants with Resistance to Multiple Dideoxynucleosides in Patients Receiving Therapy with Dideoxynucleosides. PNAS 1995, 92: 2398-2402
3) Kojima E, Shirasaka T, Anderson BD, Chokekijchai S, Steinberg SM, Broder S, Yarchoan R,
Mitsuya H. Human Immunodeficeincy Virus type I (HIV-1) Viremia changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV infection Receiving Alternating or Simultaneous Zidovudine and Didanosine Therapy. JID 1995,171: 1152-8
4) Gao W-Y, Johns DG, Chokekijchai S, Mitsuya H. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2’, 3’-dideoxynucleoside activities against replication of human immunodeficiency virus. PANS 1995, 92: 8333-8337
5) Shirasaka T, Chokekijchai S, Yamada A, Gosselin G, Imbach J-L, Mitsuya H. Comparative Analysis of Anti-Human Immunodeficiency Virus Type I Activities of Dideoxynucleoside Analogs in Resting and Activated Peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 1995, 39: 2555-2559
6) Chokekijchai S, Shirasaka T, Weinstein JN, Mitsuya H. Invitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddl. Antiviral research 1995, 28: 25-38
7) Chokekijchai S, Kojima E, Anderson S, Nomizu M, Tanaka M, Machida M, Date T, Toyota K,
Ishida S, Watanabe K, Yoshioka H, Roller PP, Murakami K, Mitsuya H. NP-06: a Novel Anti- Human Immunodeficeincy Virus Polypeptide produced by a Streptomyces Species. Antimicrobe. Agents Chemother. 1995, 39:2345-2347.
8) Sorbara LR, Maldarelli F, Chamoun G, Schilling B, Chokekijchai S, Staudt L, Mitsuya H, Simpson
IA, Zeichner SL. Human Immunodeficiency Virus Type I Infection of H9 cells Induces Increase Glucose Transporter Expression. Journal of Virology 1996, 70:7275-7279
You may hear some of these terms mentioned by your doctor. Most women don’t like to question their doctor, and leave the session no wiser than when they first made the appointment. This glossary is aimed to simplify some of the medical terms you may hear. Anterior Repair - a gynaecologic surgical procedure designed to treat a cystocele (a bulge of Anticholinergic - a class of drugs which hel
FINAL Approved: Oct. 19 /09 Safety Guidelines Version 7: Preparation (Recommendation) Guidelines for Patients Having Invasive Procedures in Medical Imaging HIGH RISK MINIMAL RISK HIGH RISK *EXCLUDED* Vascular Neuro Procedures **EXCLUDED** including cerebral angiograms Medications to be handled only by referring physicians & interventional radiologists. E